Cerner offering access to anonymous patient data for COVID-19 research, vaccine development 

Cerner is offering select health systems and research organizations access to de-identified COVID-19 patient data to help support epidemiological studies, clinical trials and medical treatments for the disease. 

Advertisement

The de-identified data is stored on Cerner’s HealtheDataLab, powered by Amazon Web Services. Healthcare providers will have free access to the database, which includes COVID-19- related information to help track disease spread and surge and detect underlying illnesses and chronic conditions, among other capabilities. 

A committee of Cerner associates and industry advisers will review applications of select recipients who will gain access to the data. 

More articles on EHRs: 
How Northwell, Cleveland Clinic & others are using EHR data during pandemic
Michigan nurse was fired for HIPPA violation, Mercy Health says
Hospitals tap Epic AI tool to identify COVID-19 patients who may need critical care

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.